Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03046862 |
|---|---|
| Brief Title: | Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer |
| First Submitted : | February 6, 2017 |
| First Submitted that Met QC Criteria : | February 6, 2017 |
| First Posted : | February 8, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 17, 2024 |
| Last Update Posted : | April 19, 2024 |